Evidence map›Paper›PMID 8389529›Full record

ArticleThe American journal of pathology1993

Reduced nm 23-H1 messenger RNA expression in metastatic lymph nodes from patients with papillary carcinoma of the thyroid.

T Arai, M Watanabe, M Onodera, T Yamashita, A Masunaga, S Itoyama, K Itoh, I Sugawara

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 34 citations in OpenAlex.

  1. NDPKA is not just a metastasis suppressor - be aware of its metastasis-promoting role in neuroblastoma.Laboratory investigation; a journal of technical methods and pathology · 2018
    Article
  2. Article
  3. Review
  4. Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.Thyroid : official journal of the American Thyroid Association · 2011
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.Journal of cancer research and clinical oncology · 1995
    Article
  11. NM23 protein in neoplastic and nonneoplastic thyroid tissues.The American journal of pathology · 1994
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

T AraiDepartment of Pathology, Saitama Medical Center, Saitama Medical School, Japan.
M Watanabe
M Onodera
T Yamashita
A Masunaga
S Itoyama
K Itoh
I Sugawara
Social Insurance Saitama Chuo Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The nm 23 gene product, which possesses nucleoside diphosphate kinase activity, is a possible mediator of cancer cell invasion and metastasis. It has been divided into two distinct gene products, nm23-H1 and nm23-H2. We have developed a method for detecting nm 23-H1 and nm 23-H2 RNA using the polymerase chain reaction, based on the amplification of complementary DNA copies of nm 23-H1 and nm 23-H2 RNA. Using this method, the nm 23-H1 and nm 23-H2 messenger (m)RNA levels in 35 thyroid papillary carcinomas, 11 metastatic lymph nodes from patients with thyroid papillary carcinomas, five thyroid follicular adenomas, and three normal thyroid tissue samples were studied. Both nm 23-H1 and nm 23-H2 mRNA were expressed ubiquitously in normal and malignant thyroid tissues. However, in metastatic lymph nodes no (3 of 11) or weak expression (8 of 11) of nm 23-H1 mRNA was observed, the extent of which was inversely proportional to the degree of cancer cell occupancy, whereas nm 23-H2 mRNA was expressed and the levels were similar to those in other tissue tested. These results show that nm 23-H1 only may play a role in cancer cell invasion and metastasis although the exact mechanisms involved have yet to be elucidated.

Indexed as

Monomeric GTP-Binding ProteinsTranscription FactorsAdenomaAdolescentAdultAgedAged, 80 and overBase SequenceCarcinoma, PapillaryDNA, NeoplasmGene Expression Regulation, NeoplasticHumansLymphatic MetastasisMiddle AgedMolecular Sequence DataNM23 Nucleoside Diphosphate KinasesDNA, NeoplasmMonomeric GTP-Binding ProteinsNM23 Nucleoside Diphosphate KinasesNME1 protein, humanNucleoside-Diphosphate KinaseProteinsRNA, MessengerTranscription Factors

Identifiers

PMID8389529
PMCPMC1886999
OpenAlexW15358203

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.